Search

Author/Creator Coeck, Carl

1. A randomised, double-blind, four-way, crossover trial comparing the 24-h FEV1 profile for once-daily versus twice-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with chronic obstructive pulmonary disease. Issue 5 (May 2015)

Authors:
Joos, Guy F.; Aumann, Joseph-Leon; Coeck, Carl; Korducki, Lawrence; Hamilton, Alan L.; Kunz, Christina; Aalbers, René
Journal:
Respiratory medicine
Issue:
Volume 109:Issue 5(2015)
Page Start:
606
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Nintedanib in Asian patients with progressive fibrosing interstitial lung diseases: Results from the INBUILD trial. Issue 5 (15th January 2023)

Authors:
Inoue, Yoshikazu; Wells, Athol U.; Song, Jin Woo; Xu, Zuojun; Kitamura, Hideya; Suda, Takafumi; Okamoto, Masaki; Müller, Heiko; Coeck, Carl; Rohr, Klaus B.; Kolb, Martin; Brown, Kevin K.
Journal:
Respirology
Issue:
Volume 28:Issue 5(2023)
Page Start:
465
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗